EGF-Receptor against Amphiregulin (AREG) Influences Costimulatory Molecules on Monocytes and T Cells and Modulates T-Cell Responses
Journal of Immunology Research · 2023
DOI: 10.1155/2023/8883045 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Immunology Research, 2023. Verfasst von Stephan Dreschers und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neonatology, University Children's Hospital, Aachen, Germany. Hauptthemen laut MEDLINE: Monocytes, Epidermal Growth Factor. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Projekt DEAL.
Abstract (Originalsprache)
Amphiregulin (AREG) is a ligand of the epidermal growth factor receptor (EGFR) and has been shown to regulate the phagocytosis-induced cell death of monocytes in peripheral blood. AREG-dependent apoptotic signaling engages factors of the intrinsic and extrinsic apoptotic pathway, such as BCL-2, BCL-XL, and death ligand/receptor CD95/CD95L. Here, we tested the hypothesis that AREG influences costimulatory monocyte functions, which are crucial for T-cell responses. We found a stronger expression of AREG and EGFR in monocytes compared to lymphocytes. As a novel function of AREG, we observed reduced T-cell proliferation following polyclonal T-cell stimulation with OKT3. This reduction of proliferation occurred in the presence of monocytes as well as in their absence, monocyte signaling being replaced by crosslinking of OKT3. Increasing concentrations of AREG down-modulated the concentration of costimulatory B7 molecules (CD80/CD86) and HLA-DR on monocytes. In proliferation assays, CD28 expression on T cells was down-modulated on the application of OKT3 but unaltered by AREG. LcK activation, following OKT3-stimulation, was reduced in T cells that had been coincubated with AREG. The effects of AREG on T-cell phenotypes were also present when monocytes were depleted and OKT3 was crosslinked. The rearranged expression of immunological synapse proteins was accompanied by an alteration of T-cell polarization. Although the proportion of regulatory T cells was not shifted by AREG, IL-17-expressing T cells were significantly enhanced, with a bias toward TH1-polarization. Taken together, these results suggest that AREG acts as an immunoregulatory molecule at the interface between antigen-presenting cells and T cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neonatology, University Children's Hospital, Aachen, Germany.
- Institute of Pharmacology and Toxicology, Medical Faculty, RWTH Aachen University, Aachen, Germany.
ORCID-Profile: Stephan Dreschers
Förderung
- Projekt DEAL
Zitieren
APA
Dreschers, S., Platen, C., Oppermann, L., Doughty, C., Ludwig, A., Babendreyer, A., & Orlikowsky, T. W. (2023). EGF-Receptor against Amphiregulin (AREG) Influences Costimulatory Molecules on Monocytes and T Cells and Modulates T-Cell Responses. Journal of Immunology Research. https://doi.org/10.1155/2023/8883045
Vancouver
Dreschers S, Platen C, Oppermann L, Doughty C, Ludwig A, Babendreyer A, et al. EGF-Receptor against Amphiregulin (AREG) Influences Costimulatory Molecules on Monocytes and T Cells and Modulates T-Cell Responses. Journal of Immunology Research. 2023. doi:10.1155/2023/8883045
BibTeX
@article{Dreschers2023,
author = {Dreschers, Stephan and Platen, Christopher and Oppermann, Louise and Doughty, Caitlin and Ludwig, Andreas and Babendreyer, Aaron and Orlikowsky, Thorsten W},
title = {EGF-Receptor against Amphiregulin (AREG) Influences Costimulatory Molecules on Monocytes and T Cells and Modulates T-Cell Responses},
journal = {Journal of Immunology Research},
year = {2023},
doi = {10.1155/2023/8883045}
}
EUVIMED